Rankings
▼
Calendar
CGEM Q1 2020 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$841M
Q1 2020 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$5M
EPS (Diluted)
$-0.26
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$98M
Cash & Equivalents
-$99M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$6M
-$5M
-7.2%
Net Income
-$5M
-$5M
-4.7%
← FY 2020
All Quarters
Q2 2020 →